Current Pharmaceutical Design
Title: Preface
Volume: 7 Issue: 17
Author(s): Alan P. Kozikowski and Pier G. Baraldi
Affiliation:
Export Options
About this article
Cite this article as:
Alan P. Kozikowski and Pier G. Baraldi , Preface, Current Pharmaceutical Design 2001; 7 (17) . https://dx.doi.org/10.2174/1381612013397159
DOI https://dx.doi.org/10.2174/1381612013397159 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
13
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
On the Nature of the Tumor-Initiating Cell
Current Stem Cell Research & Therapy Antioxidative Peptides: Trends and Perspectives for Future Research
Current Medicinal Chemistry NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation
Current Immunology Reviews (Discontinued) Targeting the p53 Pathway of Apoptosis
Current Pharmaceutical Design Artepillin C Induces Selective Oxidative Stress and Inhibits Migration and Invasion in a Comprehensive Panel of Human Cervical Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Editorial: Will Magnetic Nanomedicine Realise the Future of Therapy and Diagnosis?
Current Medicinal Chemistry From Ontology-Based Gene Function to Physiological Model
Current Bioinformatics Formulations, Pharmacodynamic and Clinical Studies of Nanoparticles for Lung Cancer Therapy - An Overview
Current Drug Metabolism 18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art
Current Radiopharmaceuticals Dissection of Signal Transduction Pathways as a Tool for the Development of Targeted Therapies of Hepatocellular Carcinoma
Reviews on Recent Clinical Trials Vascular Endothelial Cell Growth Factor (VEGF), An Emerging Target for Cancer Chemotherapy
Current Medicinal Chemistry - Anti-Cancer Agents Editorial (Thematic Issue: “Molecular Profiling and Ways Towards Personalized Medicine in Advanced Differentiated Thyroid Cancer”)
Current Genomics Targeting Ion Channels for New Strategies in Cancer Diagnosis and Therapy
Current Clinical Pharmacology The Design of Clinical Trials for New Molecularly Targeted Compounds: Progress and New Initiatives
Current Pharmaceutical Design Cranberry as Promising Natural Source of Potential Anticancer Agents: Current Evidence and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry Membrane Localization of Estrogen Receptors
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) A Review of HPLC Methods Used for Determining the Presence of Meloxicam
Current Pharmaceutical Analysis Review of Pediatric Osteoarticular Infections
Reviews on Recent Clinical Trials NADPH Oxidases and Inflammatory Bowel Disease
Current Medicinal Chemistry Nuclear Factor Erythroid 2 - Related Factor 2 Signaling in Parkinson Disease: A Promising Multi Therapeutic Target Against Oxidative Stress, Neuroinflammation and Cell Death
CNS & Neurological Disorders - Drug Targets